Form 4 for XTNT Xtant Medical Holdings, Inc.
Accepted 2023-02-17 00:00:00 ET · period of report 2023-02-15 · accession 0001235802-23-000027 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-17 | 2023-02-15 | XTNT | Schallenberger Mark A. | Chief Ops Off | A - Grant | $0.00 | +89.0K | 89.0K | New | $0 |
| D | 2023-02-17 | 2023-02-15 | XTNT | Schallenberger Mark A. | Chief Ops Off | A - Grant | $0.00 | +105.0K | 105.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.000001 par value | 2023-02-15 | A | A | 89,000 | $0.00 | 89,000 | D | — | — | (F1) These shares will vest and be issued with respect to 22,250 shares on each of February 15, 2024, February 15, 2025, February 15, 2026 and February 15, 2027 pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. Second Amended and Restated 2018 Equity Incentive Plan, conditioned upon the Reporting Person remaining an employee of Xtant through the vesting date. |
| 2 | Derivative | Stock Option (right to buy) | 2023-02-15 | A | A | 105,000 | $0.00 | 105,000 | D | $0.77 · — to 2033-02-15 | 105,000 Common Stock | (F2) This option vests with respect to 26,250 shares on February 15, 2024 and with respect to the remaining 75% of such shares over the three-year period thereafter in 12 as nearly equal as possible quarterly installments, conditioned upon the Reporting Person remaining an employee of Xtant through the vesting date. |